Sulfacetamide
규격
144-80-9CAS 번호
205-640-6EC 번호
N-(4-aminophenyl)sulfonylacetamideIUPAC 명칭
C8H10N2O3S화학식
214.24 g/mol분자량
sulfacetamide; 144-80-9; Sulphacetamide; Acetosulfamine; N-((4-Aminophenyl)sulfonyl)acetamide; N-Acetylsulfanilamide; Urosulfon; N-Sulfanilylacetamide; Acetosulfamin; Acetocid; Sulfacet; N-Sulphanilylacetamide; Formosulfacetamide; Sulfacetimide; Albamine; Sulphasil; Urosulfone; Alesten; Sulamyd; N-(4-aminophenyl)sulfonylacetamide; Sulfanilacetamide; Steramide; Region; Sulfanilazetamid; Bleph-10; p-Aminobenzenesulfonacetamide; N-Acetyl-4-aminobenzenesulfonamide; Sulfacetamida; Sulfacetamidum; Sulphacetamidum; p-Aminobenzenesulfonoacetamide; N'-Acetylsulfanilamide; N-[(4-Aminophenyl)sulfonyl]acetamide; Acetamide, N-sulfanilyl-; N-((p-Aminophenyl)sulfonyl)acetamide; A-500; Sulfanilamide, N(sup 1)-acetyl-; N(sup 1)-Acetyl-4-aminophenylsulfonamide; N-[(p-Aminophenyl)sulfonyl]acetamide; DTXSID8026060; N(1)-acetylsulfanilamide; Acetamide, N-((4-aminophenyl)sulfonyl)-; Acetamide, N-[(4-aminophenyl)sulfonyl]-; N-(p-Aminobenzenesulfonyl)acetamide; NSC-63871; Triple sulfa (sulfacetamide); CHEBI:63845; N(1)-acetyl-4-aminophenylsulfonamide; 4965G3J0F5; DTXCID406060; N-((4-aminobenzene)sulfonyl)acetamide; N-[(4-aminobenzene)sulfonyl]acetamide; Sulamyd, Sodium; AK Sulf; Belph 10; RefChem:56057; Sulfacetamida, Colircusi; Sulfacetam, Coliriocilina; D10AF06; S01AB04; sulfacylum (for the sodium-salt); 205-640-6; Albucid; Sulfacyl; Oclucid; Sebizon; Ophthel-S; Bleph-10 liquifilm; OP-Sulfa 30; Sulfacylum; N-(4-Aminobenzenesulfonyl)acetamide; N(sup1)-Acetylsulfanilamide; N-(4-Aminophenylsulfonyl)acetamide; SULSTER; MFCD00066501; NSC 63871; FML-S; CHEMBL455; MLS000069710; Solfacetamide; N-acetyl-4-amino-benzenesulfonamide; Sulfacyl (VAN); NCGC00018242-04; NCGC00018242-07; SMR000058173; Solfacetamide [DCIT]; Sulfanilazetamid [German]; N-Acetylsulfanilamine; Sulfacetamidum [INN-Latin]; Sulfacetamida [INN-Spanish]; N(sup 1)-Acetylsulfanilamide; N1-Acetylsulfanilamide; Caswell No. 808A; 5414-91-5; CAS-144-80-9; CCRIS 6273; EINECS 205-640-6; Sulfacetamide (USP/INN); EPA Pesticide Chemical Code 077904; BRN 0981718; AI3-26837; Sulfacetamide [USP:INN:BAN]; UNII-4965G3J0F5; Sulfacetamide, 1; N-[(4-Aminophenyl)sulfonyl]acetamide; Sulfacetamide; Sulfadimidine Imp. E (Pharmeuropa); Sulfadimidine Impurity E; Spectrum_000984; Sulfacetamide (Standard); Opera_ID_1990; Prestwick0_000014; Prestwick1_000014; Prestwick2_000014; Prestwick3_000014; Spectrum2_001318; Spectrum3_001017; Spectrum4_001146; Spectrum5_001230; WLN: ZR DSWMV1; SULFACETAMIDE [MI]; CBChromo1_000180; Epitope ID:952454; Sulfanilamide, N1-acetyl-; 4-acetylaminosulfonylaniline; SULFACETAMIDE [INN]; Sulfadimidine EP Impurity E; NCIOpen2_002838; Sulfacetamide, >=98.0%; Oprea1_686524; Oprea1_810285; SCHEMBL40863; BSPBio_000047; BSPBio_002773; CBDivE_013934; KBioGR_001691; KBioSS_001464; SULFACETAMIDE [VANDF]; 4-14-00-02662 (Beilstein Handbook Reference); MLS001076499; DivK1c_000227; SPECTRUM1500545; SULFACETAMIDE [MART.]; SPBio_001415; SPBio_001968; SULFACETAMIDE [WHO-DD]; SULFACETAMIDE [WHO-IP]; BPBio1_000053; orb1218800; orb1306364; orb3140131; SCHEMBL9262293; GTPL12633; HMS500L09; HY-N7123R; KBio1_000227; KBio2_001464; KBio2_004032; KBio2_006600; KBio3_001993; 4-[(acetylamino)sulfonyl]aniline; MSK4001; NINDS_000227; 4-[(acetylamino) sulfonyl]aniline; HMS1921A11; HMS2092I13; HMS2232K07; HMS3259G06; HMS3374O02; HMS5084L16; Pharmakon1600-01500545; SULFACETAMIDE [ORANGE BOOK]; Sulfacetamide, >=98.0% (NT); HY-N7123; SULFACETAMIDE (TRIPLE SULFA); SULFACETAMIDE [USP IMPURITY]; Tox21_110846; Tox21_201999; Tox21_303100; AC2473; BBL012083; BDBM50316126; CCG-39256; EBC-03499; MSK4001-100A; MSK4001-100M; NSC757323; s5546; SBB056763; STK068185; TRYSUL COMPONENT SULFACETAMIDE; SULFACETAMIDUM [WHO-IP LATIN]; SULTRIN COMPONENT SULFACETAMIDE; VAGILIA COMPONENT SULFACETAMIDE; AKOS000119729; Tox21_110846_1; AC-7630; DB00634; FS61457; KS-5327; NC00538; NSC-757323; GYNE-SULF COMPONENT SULFACETAMIDE; IDI1_000227; N-(4-Aminobenzene-1-sulfonyl)acetamide; NCGC00018242-01; NCGC00018242-02; NCGC00018242-03; NCGC00018242-05; NCGC00018242-06; NCGC00018242-08; NCGC00021857-03; NCGC00021857-04; NCGC00021857-05; NCGC00257159-01; NCGC00259548-01; ST040726; SY014752; SBI-0051519.P003; Sulfacetamide 100 |Ig/mL in Acetonitrile; DB-042749; CS-0013812; NS00010528; Sulfacetamide 100 microg/mL in Acetonitrile; EN300-18138; Sulfacetamide Solution in Methanol, 100ug/mL; SULFADIMIDINE IMPURITY E [EP IMPURITY]; D05947; T21434; AB00052094_14; F226015; SR-01000000194; Sulfacetamide Solution in Acetonitrile, 100ug/mL; Sulfacetamide, VETRANAL(TM), analytical standard; TRIPLE SULFA (SULFACETAMIDE) [ORANGE BOOK]; Q2022983; SR-01000000194-2; BRD-K21520694-001-12-3; BRD-K21520694-001-21-4; BRD-K21520694-236-02-6; N-((4-AMINOPHENYL)SULFONYL)ACETAMIDE [WHO-IP]; Z57202572; F0266-6200동의어